{"id":191,"date":"2012-05-17T16:14:37","date_gmt":"2012-05-17T16:14:37","guid":{"rendered":"http:\/\/lkksb.lv\/?p=191"},"modified":"2020-04-23T12:14:26","modified_gmt":"2020-04-23T09:14:26","slug":"prasa-valdibai-atjaunot-valsts-kompensacijas-apjomu-hroniski-slimo-pacientu-medikamentiem","status":"publish","type":"post","link":"https:\/\/lkksb.lv\/?p=191","title":{"rendered":"Prasa  vald\u012bbai atjaunot valsts kompens\u0101cijas apjomu hroniski slimo pacientu medikamentiem"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Pasaules iekais\u012bgo zarnu slim\u012bbu (IZS) dien\u0101, 2012. gada <strong>19. maij\u0101<\/strong>, R\u012bg\u0101, \u0136\u012bpsal\u0101, viesn\u012bc\u0101 \u201eIslande Hotel\u201d notiks <em>Latvijas Krona un Kol\u012bta Slimnieku biedr\u012bbas<\/em> (LKKSB) pirm\u0101 kosapulce. Taj\u0101 piedal\u012bsies ne vien biedr\u012bbas dal\u012bbnieki un IZS pacienti, bet ar\u012b Pacientu Ombuda p\u0101rst\u0101vji un&nbsp;medi\u0137i. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">K\u0101 atzina Latvijas Krona un Kol\u012bta Slimnieku biedr\u012bbas (LKKSB) valdes loceklis Zigurds Pr\u016bsis, biedr\u012bba pras\u012bs vald\u012bbai, lai uzlabojoties valsts ekonomiskajai situ\u0101cijai, t\u0101 atjauno kompens\u0101cijas apjomu hroniski slimnieku medikamentiem taj\u0101 l\u012bmen\u012b, k\u0101ds tas bija l\u012bdz 2009.gada martam. \u0160obr\u012bd ar\u012b \u0161\u012bs slim\u012bbu grupas pacienti sa\u0146em 50% valsts kompens\u0101ciju medikamentiem iepriek\u0161\u0113jo 75% viet\u0101.&nbsp;Naudas izteiksm\u0113 tas noz\u012bm\u0113, ka period\u0101, kad slim\u012bba nav saasin\u0101jusies,&nbsp;pacienta l\u012bdzmaks\u0101jums z\u0101\u013cu ieg\u0101dei ir 50 &#8211; 60 lati m\u0113nes\u012b. K\u0101 zin\u0101ms, m\u016bsu kaimi\u0146valst\u012bs Lietuv\u0101 un Igaunij\u0101 kompens\u0101cijas procenti joproj\u0101m saglab\u0101ti 80% un 90% l\u012bmen\u012b.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Turkl\u0101t, ja pacienti sa\u0146em nevis konvencion\u0101los, bet m\u016bsdien\u0101s pieejamos biolo\u0123iskos medikamentus, vi\u0146u l\u012bdzmaks\u0101juma da\u013ca ir 400 lati m\u0113nes\u012b. Tiesa, \u0161\u0101du pacientu Latvij\u0101 ir tikai tr\u012bs. Lietuv\u0101, savuk\u0101rt, valsts \u0161os jaun\u0101k\u0101s paaudzes efekt\u012bvos medikamentus apmaks\u0101 70 pacientiem. Turkl\u0101t j\u0101apzin\u0101s &#8211; ja pat vair\u0101k pacientam tiktu pie\u0161\u0137irti \u0161ie biolo\u0123iskie medikamenti &#8211; daudziem ieg\u0101d\u0101ties \u0161\u012bs z\u0101les neb\u016btu iesp\u0113jams, jo l\u012bdzmaks\u0101juma da\u013ca ir p\u0101r\u0101k augsta. Vienlaikus j\u0101atz\u012bst, ka Latvij\u0101 nepast\u0101v IZS&nbsp; pacientu re\u0123istra, l\u012bdz ar to nav iesp\u0113jams uzzin\u0101t, cik daudz cilv\u0113ku slimo ar \u0161\u012bm slim\u012bb\u0101m. Ta\u010du kl\u012bniskie dati par cit\u0101m valst\u012bm, \u013cauj izdar\u012bt pie\u0146\u0113mumu, ka to skaits var\u0113tu b\u016bt aptuveni 800 cilv\u0113ku.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cM\u016bsu biedr\u012bbas uzdevums ir piesaist\u012bt sabiedr\u012bbas, valsts un pa\u0161vald\u012bbu instit\u016bciju&nbsp;uzman\u012bbu \u0161o slim\u012bbu probl\u0113mu risin\u0101\u0161an\u0101. Krona un kol\u012bta slim\u012bbu izraiso\u0161ie simptomi bie\u017ei rada invalidit\u0101ti un l\u012bdz ar to veidojot soci\u0101li un ekonomiski atkar\u012bgu personu. T\u0101p\u0113c svar\u012bg\u0101kais uzdevums ir mazin\u0101t invalidit\u0101tes draudus un uzlabot \u0161o slimnieku dz\u012bves kvalit\u0101ti, kas iesp\u0113jams, ja tiek nodro\u0161in\u0101ts pietiekams medic\u012bniskais un soci\u0101lekonomiskais atbalsts\u201d, st\u0101sta Latvijas Krona un Kol\u012bta Slimnieku biedr\u012bbas (LKKSB) valdes loceklis Zigurds Pr\u016bsis. \u201eM\u016bsdien\u0101s, kad iesp\u0113jams \u0161\u012bs slim\u012bbas \u201dkontrol\u0113t\u201d un nepie\u013caut invalidit\u0101tes iest\u0101\u0161anos, vald\u012bbai ir j\u0101apzin\u0101s, ka tie\u0161i atbalsts \u0101rstniec\u012bbai un sadz\u012bvei ir b\u016btisk\u0101kais faktors, lai saglab\u0101tu cilv\u0113ku darbasp\u0113jas un iek\u013cau\u0161anos sabiedr\u012bb\u0101, nevis non\u0101k\u0161anu valsts pabalstu sa\u0146\u0113m\u0113ju skait\u0101\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Prof. Aldis Pu\u0137\u012btis, Latvijas Gastroenterolo\u0123ijas atbalsta biedr\u012bbas p\u0101rst\u0101vis,&nbsp;atz\u012bst, ka Krona slim\u012bba un \u010d\u016blainais kol\u012bts iev\u0113rojami apgr\u016btina pacientu ikdienas dz\u012bvi, jo slim\u012bbas simptomi &#8211; caureja, s\u0101pes v\u0113der\u0101 vai \u0137erme\u0146a masas samazin\u0101\u0161an\u0101s, rada ne vien s\u0101pes, bet ar\u012b psiholo\u0123iskas un soci\u0101lekonomiskas sekas. \u201cIekais\u012bgo zarnu slim\u012bbu ietekme uz pacientu dz\u012bves kvalit\u0101ti ir saist\u012bta ne tikai ar slim\u012bbas izpausm\u0113m, bet ar\u012b citiem aspektiem, piem\u0113ram, izgl\u012bt\u012bbas ieg\u016b\u0161anas un nodarbin\u0101t\u012bbas iesp\u0113j\u0101m, cilv\u0113ku attiec\u012bb\u0101m un invalidit\u0101tes rad\u012btaj\u0101m sek\u0101m. Lai gan IZS var izpausties jebkur\u0101 vecum\u0101, diagnoze tiek noteikta arvien jaun\u0101kiem cilv\u0113kiem, parasti starp 20&nbsp;un 40&nbsp;gadiem\u201d, atz\u012bst&nbsp;Aldis Pu\u0137\u012btis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">IZS ir saist\u012btas ar organisma im\u016bnreakciju pret savu zarnu traktu, kad notiek da\u017eu org\u0101nu pa\u0161izn\u012bcin\u0101\u0161an\u0101s. Krona slim\u012bbas saslimst\u012bbas l\u012bmenis pasaul\u0113 ir robe\u017e\u0101s no 0,1 l\u012bdz 11 pacientiem uz 100 000 iedz\u012bvot\u0101jiem, ar tendenci izplat\u012bbas r\u0101d\u012bt\u0101jiem pieaugt l\u012bdz pat 396 cilv\u0113kiem uz 100 000 iedz\u012bvot\u0101jiem.&nbsp;Savuk\u0101rt \u010d\u016blainais kol\u012bts ir slim\u012bba, kas izraisa resn\u0101s zarnas boj\u0101jumus. Vid\u0113jais vecums, kad cilv\u0113kiem tiek \u0161\u012b diagnoze, ir ap 35 gadiem, tom\u0113r slim\u012bba var par\u0101d\u012bties jebkur\u0101 vecum\u0101. \u010c\u016blainais kol\u012bts ir \u201crecidiv\u0113jo\u0161a un remit\u0113jo\u0161a\u201d slim\u012bba, tas noz\u012bm\u0113, ka simptomi var izzust un p\u0113c tam atkal periodiski saasin\u0101ties. \u010c\u016blain\u0101 kol\u012bta saasin\u0101jumi var b\u016bt p\u0113k\u0161\u0146i un smagi. P\u0113c tiem pacientiem iesp\u0113jami ilgi periodi, kad simptomi ir viegli vai to visp\u0101r nav.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Eiropas Krona slim\u012bbas un \u010d\u016blain\u0101 kol\u012bta asoci\u0101ciju feder\u0101cija jeb <em>EFCCA<\/em> febru\u0101r\u012b Barselon\u0101 Eiropas Krona slim\u012bbas un \u010d\u016blain\u0101 kol\u012bta speci\u0101listu kongres\u0101 prezent\u0113ja p\u0113t\u012bjumu, kas liecina, ka IZS gal\u012bg\u0101 diagnoze tiek noteikta savlaic\u012bgi, tom\u0113r aptuveni 18% pacientu l\u012bdz diagnozes noteik\u0161anai j\u0101gaida ilg\u0101k nek\u0101 pieci gadi. Tas var b\u016bt neskaidr\u012bbas periods, kas ietekm\u0113 ikdienas dz\u012bvi, slim\u012bbas un stresa pak\u0101pi. 64% pacientu neatliekama pal\u012bdz\u012bba var b\u016bt nepiecie\u0161ama PIRMS diagnozes noteik\u0161anas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">74% IZS pacientu slim\u012bbas d\u0113\u013c p\u0113d\u0113j\u0101 gad\u0101 k\u0101du laiku nav str\u0101d\u0101ju\u0161i, turkl\u0101t vair\u0101k nek\u0101 viens no katriem \u010detriem respondentiem p\u0113d\u0113j\u0101 gad\u0101 darb\u0101 nav bijis vair\u0101k nek\u0101 25&nbsp;dienas. 25% pacientu, kam ir IZS, darb\u0101 ir sa\u0146\u0113mu\u0161i pretenzijas vai netaisn\u012bgus koment\u0101rus, vai ar\u012b cietu\u0161i no diskrimin\u0101cijas. IZS&nbsp;ir rakstur\u012bga noz\u012bm\u012bga negat\u012bva soci\u0101la ietekme, un satrauco\u0161i liela da\u013ca cilv\u0113ku (40%) ir apgalvoju\u0161i, ka IZS ir likusi izvair\u012bties no tuv\u0101m attiec\u012bb\u0101m vai t\u0101s p\u0101rtraukt.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pasaules iekais\u012bgo zarnu slim\u012bbu (IZS) dien\u0101, 2012. gada 19. maij\u0101, R\u012bg\u0101, \u0136\u012bpsal\u0101, viesn\u012bc\u0101 \u201eIslande Hotel\u201d notiks Latvijas Krona un Kol\u012bta Slimnieku biedr\u012bbas (LKKSB) pirm\u0101 kosapulce. Taj\u0101 piedal\u012bsies ne vien biedr\u012bbas dal\u012bbnieki un IZS pacienti, bet ar\u012b Pacientu Ombuda p\u0101rst\u0101vji un&nbsp;medi\u0137i. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1406,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-191","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/lkksb.lv\/index.php?rest_route=\/wp\/v2\/posts\/191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lkksb.lv\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lkksb.lv\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lkksb.lv\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lkksb.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=191"}],"version-history":[{"count":8,"href":"https:\/\/lkksb.lv\/index.php?rest_route=\/wp\/v2\/posts\/191\/revisions"}],"predecessor-version":[{"id":1436,"href":"https:\/\/lkksb.lv\/index.php?rest_route=\/wp\/v2\/posts\/191\/revisions\/1436"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lkksb.lv\/index.php?rest_route=\/wp\/v2\/media\/1406"}],"wp:attachment":[{"href":"https:\/\/lkksb.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lkksb.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lkksb.lv\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}